To investigate how altered C3orf21 expression modulated the anti-NSCLC effect of beta-elemene, we first tested the impact of beta-elemene on A549 and PC-9 cell viability by CCK-8 assays. The gene discussed is XXYLT1; the disease is non-small cell lung carcinoma.